Mannitol Fresenius

Mannitol, the active ingredient in Mannitol Fresenius, is an osmotic diuretic presented as a sterile injection solution for intravenous use. It creates an osmotic gradient that draws water from intracellular and interstitial spaces into the vascular compartment, thereby reducing intracranial pressure and providing renal protection during nephrotoxic procedures.

GNH USA supplies Mannitol Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and intensive‑care units worldwide.

Mannitol is used as an osmotic agent in several clinical situations where reduction of fluid volume or pressure is required.

- Reduction of intracranial pressure: lowers cerebral edema and intracranial pressure in traumatic brain injury or neurosurgical patients. - Renal protection during nephrotoxic procedures: helps preserve renal function during contrast‑enhanced imaging or other nephrotoxic interventions. - Promotion of diuresis in acute renal failure: facilitates urine output in patients with oliguria or anuria.

Mannitol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea and vomiting: transient gastrointestinal upset. - Electrolyte imbalance (e.g., hypernatremia): due to water shift. - Hypotension: especially with rapid infusion. - Dizziness or light‑headedness. - Thirst or dry mouth.

Serious or Rare Side Effects: - Pulmonary edema: fluid overload in susceptible patients. - Severe allergic reaction or anaphylaxis: rash, bronchospasm, hypotension. - Worsening renal failure: especially in pre‑existing severe kidney disease. - Cardiac arrhythmias: secondary to electrolyte disturbances. - Hemolysis: rare but reported with high‑dose therapy.

When using Mannitol, clinicians should observe several safety measures.

- Monitor electrolytes: check serum sodium and osmolarity regularly. - Assess intracranial pressure: ensure appropriate indication before infusion. - Adjust infusion rate: avoid rapid administration to prevent hemodynamic shifts. - Use caution in heart failure: patients may be prone to fluid overload. - Avoid in severe renal impairment: risk of accumulation and toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with other agents that affect fluid balance or renal function.

Major Interactions (Avoid): - Loop diuretics: may cause excessive diuresis and electrolyte loss. - Lithium: osmotic shifts can increase lithium reabsorption, raising toxicity risk. - Amphotericin B: combined renal stress may exacerbate nephrotoxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt diuretic response and affect renal perfusion. - Antihypertensives: monitor blood pressure as Mannitol can cause hypotension.